Sleep deprivation differentially impairs cognitive performance in abstinent methylenedioxymethamphetamine ("ecstasy") users

Journal of Neuroscience

Volumn 29, Issue 44, 2009, Pages 14050-14056

  McCann, Una D ^a   Wilson, Michael J ^a   Sgambati, Francis P ^a   Ricaurte, George A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ETHYLENEDIOXYMETHAMPHETAMINE; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; IMPULSIVENESS; MALE; MEDICAL RESEARCH; PRIORITY JOURNAL; SHORT TERM MEMORY; SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP PATTERN; TASK PERFORMANCE;

ADULT; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PSYCHOMOTOR PERFORMANCE; SLEEP DEPRIVATION; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 70449372255     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4654-09.2009     Document Type: Article

References (56)

1. Alhola P, Polo-Kantola P (2007) Sleep deprivation: impact on cognitive performance. Neuropsychiatr Dis Treat 3:553-567. (Pubitemid 350090286)
2. Angus RG, Heslegrave RJ (1985) Effects of sleep and sustained cognitive performance during a command and control situation. Behav Res Methods 17:55-67.
3. Banks S, Dinges DF (2007) Behavioral and physiological consequences of sleep restriction. J Clin Sleep Med 3:519-528. (Pubitemid 47378257)
4. Bolla KI, McCann UD, Ricaurte GA (1998) Memory impairment in abstinent MDMA ("ecstasy") users. Neurology 51:1532-1537. (Pubitemid 28565228)
5. Buchert R, Thomasius R, Nebeling B, Petersen K, Obrocki J, Jenicke L, Wilke F, Wartberg L, Zapletalova P, Clausen M (2003) Long-term effects of "ecstasy" use on serotonin transporters of the brain investigated by PET. J Nucl Med 44:375-384.
6. Buchert R, Thomasius R, Wilke F, Petersen K, Nebeling B, Obrocki J, Schulze O, Schmidt U, Clausen M (2004) A voxel-based PET investigation of the long-term effects of "ecstasy" consumption on brain serotonin transporters. Am J Psychiatry 161:1181-1189.
7. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index (PSQI): a new instrument for psychiatric research and practice. Psychiatry Res 28:193-213.
8. Carskadon MA, Acebo C, Jenni OG (2004) Regulation of adolescent sleep: implications for behavior. Ann N Y Acad Sci 1021:276-291.
9. Colado MI, O'Shea E, Granados R, Murray TK, Green AR (1997) In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ("Ecstasy") and p-chloroamphetamine but not the degeneration following fenfluramine. Br J Pharmacol 121:889-900.
10. Daumann J, Fischermann T, Heekeren K, Henke K, Thron A, Gouzoulis-Mayfrank E (2005) Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users. Psychopharmacology (Berl) 180:607-611.
11. de Win MML, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, den Heeten GJ, van den Brink W (2008) Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain 131:2936-2945.
12. Dinges DF, Kribbs NB (1991) Performing while sleepy: effects of experimentally induced sleepiness. In: Sleep, sleepiness and performance (Monk TH, ed), pp 97-128. Chichester, UK: Wiley.
13. First MB, Spitzer RL, Gibbon M, Williams JB (1997) Structured clinical interview for DSM-IV Axis I disorders (SCID-I), clinician version. Arlington, VA: American Psychiatric Publishers Inc.
14. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 55:463-508. (Pubitemid 37013213)
15. Hatzidimitriou G, McCann UD, Ricaurte GA (1999) Altered serotonin innervation patterns in the forebrain of monkeys treated with (±)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 19:5096-5107. (Pubitemid 29270144)
16. Hollander E, Rosen J (2000) Impulsivity. J Psychopharmacol 14:S39-S44.
17. Johnston LD, O'Malley PM, Bachman, JG, Schulenberg, JE (2009) Monitoring the future national results on adolescent drug use: overview of key findings, 2008 (NIH Publication No. 09-7401). Bethesda, MD: NIDA.
18. Kalechstein AD, De La Garza R 2nd, Mahoney JJ 3rd, Fantegrossi WE, Newton TF (2007) MDMA use and neurocognition: a meta-analytic review. Psychopharmacology (Berl) 189:531-537. (Pubitemid 44791222)
19. Kenny DA (2009) Mediation. Retrieved September 30, 2009. Available from http://davidakenny.net/cm/mediate.htm.
20. King MV, Marsden CA, Fone KC (2008) A role for the 5-HT(1A), 5-HT(4) and 5-HT(6) receptors in learning and memory. Trends Pharmacol Sci 29:482-492.
21. Kish S, Fitzmaurice P, Chang L, Furukawa Y, Tong J (2008) Low striatal serotonin transporter protein in a human polydrug MDMA (ecstasy) user: a case study. J Psychopharmacol. Advance online publication. Retrieved October 15, 2009. doi: 10.1177/0269881108097724.
22. Kleitman N (1963) Sleep and wakefulness, Ed 2. Chicago: University of Chicago.
23. Lim J, Dinges DF (2008) Sleep deprivation and vigilant attention. Ann N Y Acad Sci 1129:305-322.
24. MacKinnon DP, Lockwood CM, Williams J (2004) Confidence limits for the indirect effect: distribution of the product and resampling methods. Multivar Behav Res 39:99-128.
25. McCann UD, Ricaurte GA (2007) Effects of (+/-)3,4- methylenedioxymethamphetamine (MDMA) on sleep and circadian rhythms. Sci World J 7:231-238. (Pubitemid 350277584)
26. McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA (1998) Positron emission tomographic evidence of toxic effect of MDMA ("ecstasy") on brain serotonin neurons in human beings. Lancet 352:1433-1437. (Pubitemid 28510877)
27. McCann UD, Mertl M, Eligulashvili V, Ricaurte GA (1999) Cognitive performance in (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study. Psychopharmacology (Berl) 143:417-425.
28. McCann UD, Szabo Z, Seckin E, Rosenblatt P, Mathews WB, Ravert HT, Dannals RF, Ricaurte GA (2005) Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB. Neuropsychopharmacology 30:1741-1750.
29. McCann UD, Peterson SC, Ricaurte GA (2007) The effect of catecholamine depletion by alpha-methyl-para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users. Neuropsychopharmacology 32:1695-1706.
30. McCann UD, Szabo Z, Vranesic M, Palermo M, Mathews WB, Ravert HT, Dannals RF, Ricaurte GA (2008) Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4 methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance. Psychopharmacology (Berl) 200:439-450.
31. Mechan A, Yuan J, Hatzidimitriou G, Irvine RJ, McCann UD, Ricaurte GA (2006) Pharmacokinetic profile of single and repeated oral doses of MDMA in squirrel monkeys: relationship to lasting effects on brain serotonin neurons. Neuropsychopharmacology 31:339-350. (Pubitemid 43113398)
32. Moeller FG, Steinberg JL, Dougherty DM, Narayana PA, Kramer LA, Renshaw PF (2004) Functional MRI study of working memory in MDMA users. Psychopharmacology (Berl) 177:185-194.
33. Morgan MJ, Impallomeni LC, Pirona A, Rogers RD (2006) Elevated impulsivity and impaired decision-making in abstinent ecstasy (MDMA) users compared to polydrug and drug-naive controls. Neuropsychopharmacology 31:1562-1573. (Pubitemid 43910451)
34. Newhouse PA, Belenky G, Thomas M, Thorne D, Sing HC, Fertig J (1989) The effects of d-amphetamine on arousal, cognition and mood after prolonged total sleep deprivation. Neuropsychopharmacology 2:153-164.
35. O'Brien EM, Mindell JA (2005) Sleep and risk-taking behavior in adolescents. Behav Sleep Med 3:113-133.
36. O'Hearn E, Battaglia G, De Souza EB, Kuhar MJ, Molliver ME (1988) Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J Neurosci 8:2788-2803. (Pubitemid 18219068)
37. Oquendo MA, Mann JJ (2000) The biology of impulsivity and suicidality. Psychiatr Clin North Am 23:11-25.
38. Parrott AC (2000) Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change. Neuropsychobiology 42:17-24.
39. Quednow BB, Kuhn KU, Hoppe C, Westheide J, Maier W, Daum I, Wagner M (2007) Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("ecstasy"). Psychopharmacology (Berl) 189:517-530. (Pubitemid 44791221)
40. Raj V, Liang H, Woodward N, Bauernfeind A, Lee J, Dietrich M, Park S, Cowan R (2009) MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study. J Psychopharmacol (Berl). Advance online publication. Retrieved October 15, 2009. doi:10.1177/0269881109103203.
41. Reneman L, Lavalaye J, Schmand B, de Wolff FA, van den Brink W, den Heeten GJ, Booij J (2001) Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings. Arch Gen Psychiatry 58:901-906. (Pubitemid 32937910)
42. Ricaurte GA, DeLanney LE, Wiener SG, Irwin I, Langston JW (1988) 5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4 methylenedioxymethamphetamine in CNS of non-human primates. Brain Res 474:359-363. (Pubitemid 18272321)
43. Ricaurte GA, Martello AL, Katz JL, Martello MB (1992) Lasting effects of (+/-)3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. J Pharmacol Exp Ther 261:616-622.
44. Salkind NJ, Wright JC (1977) The development of reflection-impulsivity and cognitive efficiency: an integrated model. Hum Dev 20:377-387.
45. Scheffel U, Szabo Z, Mathews WB, Finley PA, Dannals RF, Ravert HT, Szabo K, Yuan J, Ricaurte GA (1998) In vivo detection of short-and long-term MDMA neurotoxicity - a positron emission tomography study in the living baboon brain. Synapse 29:183-192.
46. Schilt T, de Win MM, Koeter M, Jager G, Korf DJ, van den Brink W, Schmand B (2007) Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Arch Gen Psychiatry 64:728-736. (Pubitemid 46878673)
47. Schilt T, de Win MM, Jager G, Koeter MW, Ramsey NF, Schmand B, van den Brink W (2008) Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users. Psychol Med 38:1309-1317.
48. Schmidt CJ (1987) Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J Pharmacol Exp Ther 240:1-7.
49. Schmitt JA, Wingen M, Ramaekers JG, Evers EA, Riedel WJ (2006) Serotonin and human cognitive performance. Curr Pharm Des 12:2473-2486.
50. Selig JP, Preacher KJ, eds (2009) Monte Carlo method for assessing mediation. The University of Kansas. Retrieved September 29, 2009. Available at http://www.people.ku.edu/~preacher/medmc/medmc.htm.
51. Semple DM, Ebmeier KP, Glabus MF, O'Carroll RE, Johnstone EC (1999) Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ("ecstasy") users. Br J Psychiatry 175:63-69.
52. Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A (2006) Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. J Psychopharmacol 20:211-225.
53. Thorne DR, Genser SG, Sing HC, Hegge FK (1985) The Walter Reed Performance Assessment Battery. Neurobehav Toxicol Teratol 7:415-418.
54. Webb W, Levy C (1982) Age, sleep deprivation and performance. Psychophysiology 19:272-276.
55. Wechsler D (1981) Wechsler adult intelligence scale-revised: manual. New York: Psychological Corporation.
56. Zakzanis KK, Campbell Z, Jovanovski D (2007) The neuropsychology of ecstasy (MDMA) use: a quantitative review. Hum Psychopharmacol 22:427-435. (Pubitemid 47611297)